Aysun Aybal Kutlugun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aysun Aybal Kutlugun has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Cetin Turgan
Department of Nephrology, Ankara, Turkey
3 shared publications- Bulent Altun
Hacettepe University
2 shared publications Fatma Ayerden Ebinc
Department of Nephrology, Keçioren Education and Research Hospital, Ankara, Turkey
2 shared publications- Fatma Kaplan Efe
Department of Internal Medicine, Division of Geriatrics, Ankara Bilkent City Hospital, Ankara, Türkiye
2 shared publications - Fazil Tuncay Aki
Department of Urology Hacettepe University Faculty of Medicine Ankara Turkey
2 shared publications Mahmut Altindal
Department of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey
2 shared publications
Latest Publications
- Open Access
- 26 July 2022
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 00
Yeni tanı konulan hipertansif hastalarda antihipertansif ilaç başlanmasının MPV düzeyine etkisi
Trombosit aktivasyonu hipertansiyon patogenezinde rol oynayan bir faktördür. Ayrıca, trombotik olayların gelişimine ve hipertansiyona bağlı hedef organ hasarına katkıda bulunur. Mean platelet volume, platelet aktivasyonunu gösteren kolay ölçülebilir bir parametredir. Bu çalışmanın amacı, yeni tanı almış hipertansif hastalarda antihipertansif ilaç tedavisine başlandıktan sonra MPV düzeylerinde herhangi bir değişiklik olup olmadığını değerlendirmektir. Antihipertansif ilaç tedavisine başlanan 79 hasta retrospektif olarak değerlendirildi. Hastaların% 24.1'inde mikroalbüminüri vardı. Antihipertansif ilacın başlamasından önceki ve sonraki MPV değerleri (5.8=3.6 ay) istatistiksel olarak karşılaştırıldı. Antihipertansif ilaç tedavisine başlandıktan sonra ortalama MPV değerinde istatistiksel olarak anlamlı azalma saptandı (8.92=1.76 fl'ye karşılık 8.38=1.60 fL, p<0.001). Ortalama MPV değeri mikroalbüminürik grupta normoalbüminürik gruba göre daha yüksekti (9.24=1.10 fLvs. 8.49 = 1.75 fL, p = 0.028). Yeni tanı konulan hipertansif hastalarda antihipertansif ilaç başlanmasını takip eden ilk yıl içinde ortalama MPV düzeyinde anlamlı bir azalma tespit edildi.
- 26 July 2022
- Published by Osmangazi Journal of Medicine in OSMANGAZİ JOURNAL OF MEDICINE
- Vol. 00
Open AccessYeni tanı konulan hipertansif hastalarda antihipertansif ilaç başlanmasının MPV düzeyine etkisi
Trombosit aktivasyonu hipertansiyon patogenezinde rol oynayan bir faktördür. Ayrıca, trombotik olayların gelişimine ve hipertansiyona bağlı hedef organ hasarına katkıda bulunur. Mean platelet volume, platelet aktivasyonunu gösteren kolay ölçülebilir bir parametredir. Bu çalışmanın amacı, yeni tanı almış hipertansif hastalarda antihipertansif ilaç tedavisine başlandıktan sonra MPV düzeylerinde herhangi bir değişiklik olup olmadığını değerlendirmektir. Antihipertansif ilaç tedavisine başlanan 79 hasta retrospektif olarak değerlendirildi. Hastaların% 24.1'inde mikroalbüminüri vardı. Antihipertansif ilacın başlamasından önceki ve sonraki MPV değerleri (5.8=3.6 ay) istatistiksel olarak karşılaştırıldı. Antihipertansif ilaç tedavisine başlandıktan sonra ortalama MPV değerinde istatistiksel olarak anlamlı azalma saptandı (8.92=1.76 fl'ye karşılık 8.38=1.60 fL, p<0.001). Ortalama MPV değeri mikroalbüminürik grupta normoalbüminürik gruba göre daha yüksekti (9.24=1.10 fLvs. 8.49 = 1.75 fL, p = 0.028). Yeni tanı konulan hipertansif hastalarda antihipertansif ilaç başlanmasını takip eden ilk yıl içinde ortalama MPV düzeyinde anlamlı bir azalma tespit edildi.
- Open Access
- 30 November 2021
- Published by Balikesir Medical Journal in Balıkesir Medical Journal
- Vol. 5 (3) , 151-156
The Relationship Between Arterial Stiffness and Helicobacter Pylori Infection
Aim:Studies have found the association of Helicobacter Pylori (Hp) seropositivity with cardiovascular diseases and it has been shown that chronic inflammation with Hp may be related to early atherosclerosis. The aim of this study is to evaluate the relationship between Hp positivity detected by endoscopic gastric biopsy and arterial stiffness. Material and Method: In this cross-sectional study, patients were divided into 2 groups as Hp positive (n=48) and Hp negative (n=61) according to endoscopic gastric biopsy findings. Augmentation index, arterial stiffness and central blood pressure were measured using Pulse wave velocity analysis/Ambulatory blood pressure monitoring in all patients. Results: Augmentation index was significantly higher in the Hp positive group (p=0.020). There was no correlation between central blood pressure and augmentation index and the intensity of Hp colonization (p=0.070, r=0.263). However, logistic regression analysis revealed that positive Hp (OR: 3.593, 95%CI: 1.341-9,629, p=0.011) was the only variable predictive for an augmentation index > 24.9 among variables including, age, BMI, systolic and diastolic blood pressure, central blood pressure, glucose, creatinine, total cholesterol, C-reactive protein, and positive Hp. Conclusion: Helicobacter Pylori positive patients with confirmed biopsy have an increased arterial stiffness. Moreover, presence of Hp infection is predictive for an increased arterial stiffness. Regarding the diversity and frequency of Hp worldwide long term follow up studies with larger sample size are needed to elaborate the mechanism of this relationship.
- 30 November 2021
- Published by Balikesir Medical Journal in Balıkesir Medical Journal
- Vol. 5 (3) , 151-156
Open AccessThe Relationship Between Arterial Stiffness and Helicobacter Pylori Infection
Aim:Studies have found the association of Helicobacter Pylori (Hp) seropositivity with cardiovascular diseases and it has been shown that chronic inflammation with Hp may be related to early atherosclerosis. The aim of this study is to evaluate the relationship between Hp positivity detected by endoscopic gastric biopsy and arterial stiffness. Material and Method: In this cross-sectional study, patients were divided into 2 groups as Hp positive (n=48) and Hp negative (n=61) according to endoscopic gastric biopsy findings. Augmentation index, arterial stiffness and central blood pressure were measured using Pulse wave velocity analysis/Ambulatory blood pressure monitoring in all patients. Results: Augmentation index was significantly higher in the Hp positive group (p=0.020). There was no correlation between central blood pressure and augmentation index and the intensity of Hp colonization (p=0.070, r=0.263). However, logistic regression analysis revealed that positive Hp (OR: 3.593, 95%CI: 1.341-9,629, p=0.011) was the only variable predictive for an augmentation index > 24.9 among variables including, age, BMI, systolic and diastolic blood pressure, central blood pressure, glucose, creatinine, total cholesterol, C-reactive protein, and positive Hp. Conclusion: Helicobacter Pylori positive patients with confirmed biopsy have an increased arterial stiffness. Moreover, presence of Hp infection is predictive for an increased arterial stiffness. Regarding the diversity and frequency of Hp worldwide long term follow up studies with larger sample size are needed to elaborate the mechanism of this relationship.
- 19 February 2021
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 43 (4) , 373-377
Relationship between renal volume and atherosclerosis in nondiabetic hypertensive patients with normal glomerular filtration rate
Background: The association between cystatin C (CysC) and atherosclerosis has been shown in numerous studies in hypertensive patients and in various patient groups with high cardiovascular risk. The study examining the association between renal volume and atherosclerosis is very limited. This study aimed to investigate whether there is an association between the presence of atherosclerosis with CysC and renal volume in hypertensive patients. Methods: 133 hypertensive patients and 80 healthy volunteers were evaluated. CysC level was studied in the blood sample taken from all participants. Carotid intima media thickness (CIMT) and renal volume were measured with ultrasound always by the same radiologist. Laboratory findings, CysC, CIMT, and renal volume measurements of the groups were compared statistically. Results: There was no significant difference in mean renal volume values between hypertension and control groups. There was no significant correlation between renal volume with albuminuria and proteinuria. CIMT was significantly higher in hypertension group than in control group (p = .003). There was a significant correlation between renal volume and CIMT, which is an indicator of subclinical atherosclerosis (r = 0.213, p = .001). Renal volume was found to be an independent predictor of CIMT when corrected with variables such as age, BMI, serum LDL-cholesterol level, creatinine, CysC, and albumin-to-creatinine ratio. Conclusion: Ultrasonographic renal volume measurement, which is easy to perform and does not take a long time, can be a useful method for predicting the presence of atherosclerosis in hypertensive patients with GFR >60 ml/min.
- 19 February 2021
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 43 (4) , 373-377
Relationship between renal volume and atherosclerosis in nondiabetic hypertensive patients with normal glomerular filtration rate
Background: The association between cystatin C (CysC) and atherosclerosis has been shown in numerous studies in hypertensive patients and in various patient groups with high cardiovascular risk. The study examining the association between renal volume and atherosclerosis is very limited. This study aimed to investigate whether there is an association between the presence of atherosclerosis with CysC and renal volume in hypertensive patients. Methods: 133 hypertensive patients and 80 healthy volunteers were evaluated. CysC level was studied in the blood sample taken from all participants. Carotid intima media thickness (CIMT) and renal volume were measured with ultrasound always by the same radiologist. Laboratory findings, CysC, CIMT, and renal volume measurements of the groups were compared statistically. Results: There was no significant difference in mean renal volume values between hypertension and control groups. There was no significant correlation between renal volume with albuminuria and proteinuria. CIMT was significantly higher in hypertension group than in control group (p = .003). There was a significant correlation between renal volume and CIMT, which is an indicator of subclinical atherosclerosis (r = 0.213, p = .001). Renal volume was found to be an independent predictor of CIMT when corrected with variables such as age, BMI, serum LDL-cholesterol level, creatinine, CysC, and albumin-to-creatinine ratio. Conclusion: Ultrasonographic renal volume measurement, which is easy to perform and does not take a long time, can be a useful method for predicting the presence of atherosclerosis in hypertensive patients with GFR >60 ml/min.
- Open Access
- 1 January 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (6) , 3047-3052
Investigation of the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on anemia in patients with normal or mildly low glomerular filtration rate
The relationship between the activation of the renin-angiotensin system and the increase in erythropoiesis has been shown in many studies. In addition, the use of angiotensin converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARB) has been reported to reduce hemoglobin levels in various patient groups at risk for secondary erythrocytosis/polycythemia. The aim of our study is to investigate whether there is a change in hemoglobin levels after starting ACEIs or ARBs in patients who have not used them before. Three hundred and fifty-one patients who were started on renin angiotensin aldosterone system (RAAS) blockers were evaluated retrospectively. None of the patients had anemia before starting RAAS blockers. A median of 6 (4–12) months after the start of the drug, complete blood count and kidney function tests were evaluated. Hemoglobin values before and after the start of the drug were compared statistically. A statistically significant decrease in mean Hb value was found after starting ACEIs or ARBs (14.39± 1.29 g/dL vs 13.98 ± 1.36 g/dL, p < 0.001). The decrease in control Hb values was higher in the ARB group than in the ACEI group (–0.53 ± 0.06 g/dL vs –0.29 ± 0.06 g/dL, p < 0.001). A significant decrease in mean Hb level was detected in the first year following the first administration of ACEIs or ARBs.
- 1 January 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (6) , 3047-3052
Open AccessInvestigation of the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on anemia in patients with normal or mildly low glomerular filtration rate
The relationship between the activation of the renin-angiotensin system and the increase in erythropoiesis has been shown in many studies. In addition, the use of angiotensin converting enzyme inhibitors (ACEIs) or angiotensin-receptor blockers (ARB) has been reported to reduce hemoglobin levels in various patient groups at risk for secondary erythrocytosis/polycythemia. The aim of our study is to investigate whether there is a change in hemoglobin levels after starting ACEIs or ARBs in patients who have not used them before. Three hundred and fifty-one patients who were started on renin angiotensin aldosterone system (RAAS) blockers were evaluated retrospectively. None of the patients had anemia before starting RAAS blockers. A median of 6 (4–12) months after the start of the drug, complete blood count and kidney function tests were evaluated. Hemoglobin values before and after the start of the drug were compared statistically. A statistically significant decrease in mean Hb value was found after starting ACEIs or ARBs (14.39± 1.29 g/dL vs 13.98 ± 1.36 g/dL, p < 0.001). The decrease in control Hb values was higher in the ARB group than in the ACEI group (–0.53 ± 0.06 g/dL vs –0.29 ± 0.06 g/dL, p < 0.001). A significant decrease in mean Hb level was detected in the first year following the first administration of ACEIs or ARBs.
- Open Access
- 1 March 2018
- Published by Walter de Gruyter GmbH in Romanian Journal of Internal Medicine
- Vol. 56 (1) , 21-26
Association of neutrophil-to-lymphocyte ratio and microalbuminuria in patients with normal eGFR
Aims. The aim of this study was to evaluate the association between neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and microalbuminuria in patients with normal estimated glomerular filtration rate (eGFR). Methods. 174 patients who had eGFR ≥ 60 mL/min/1.73 m2 were studied. Patients were divided into two groups according to the urinary albumin excretion as microalbuminuric group (n = 105) and normoalbuminuric group (n = 69). NLR and PLR levels were calculated. Results. NLR was significantly higher (p < 0.05) in microalbuminuric patients (1.91 ± 0.70) compared with normoalbuminuric patients (1.63 ± 0.53). A positive correlation was found between urine albumin excretion and NLR in the whole study group (r = 0.214, p < 0.005). Conclusions. Higher NLR levels were found in microalbuminuric patients with normal eGFR. Also a significant positive correlation was observed between albuminuria and NLR.
- 1 March 2018
- Published by Walter de Gruyter GmbH in Romanian Journal of Internal Medicine
- Vol. 56 (1) , 21-26
Open AccessAssociation of neutrophil-to-lymphocyte ratio and microalbuminuria in patients with normal eGFR
Aims. The aim of this study was to evaluate the association between neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and microalbuminuria in patients with normal estimated glomerular filtration rate (eGFR). Methods. 174 patients who had eGFR ≥ 60 mL/min/1.73 m2 were studied. Patients were divided into two groups according to the urinary albumin excretion as microalbuminuric group (n = 105) and normoalbuminuric group (n = 69). NLR and PLR levels were calculated. Results. NLR was significantly higher (p < 0.05) in microalbuminuric patients (1.91 ± 0.70) compared with normoalbuminuric patients (1.63 ± 0.53). A positive correlation was found between urine albumin excretion and NLR in the whole study group (r = 0.214, p < 0.005). Conclusions. Higher NLR levels were found in microalbuminuric patients with normal eGFR. Also a significant positive correlation was observed between albuminuria and NLR.
- Open Access
- 31 December 2017
- Published by ClinMed International Library in Journal of Clinical Nephrology and Renal Care
- Vol. 3 (2)
Frequency of Hyperkalemia in Chron?c Kidney Patients Under Regular Nephrology Care
Hyperkalemia is an important life-threatening electrolyte disorder and one of the most important complications of Chronic Kidney Disease (CKD). Decreased Potassium (K) excretion due to decreased glomerular filtration rate and reduced tubular secretion due to tubulointerstitial dysfunction lead to abnormal K balance and hyperkalaemia in CKD. In addition, the use of Renin Angiotensin Aldosterone System (RAAS) blockers, which are important in the treatment of CKD, and the presence of Diabetes Mellitus (DM) also cause hyperkalemia by decreasing urinary potassium excretion. Metabolic acidosis associated with renal failure leads to potassium shift from intracellular to extracellular and thus hyperkalemia. Most of the daily potassium is excreted by the kidneys while the remaining 5-10% is eliminated by the colon.
- 31 December 2017
- Published by ClinMed International Library in Journal of Clinical Nephrology and Renal Care
- Vol. 3 (2)
Open AccessFrequency of Hyperkalemia in Chron?c Kidney Patients Under Regular Nephrology Care
Hyperkalemia is an important life-threatening electrolyte disorder and one of the most important complications of Chronic Kidney Disease (CKD). Decreased Potassium (K) excretion due to decreased glomerular filtration rate and reduced tubular secretion due to tubulointerstitial dysfunction lead to abnormal K balance and hyperkalaemia in CKD. In addition, the use of Renin Angiotensin Aldosterone System (RAAS) blockers, which are important in the treatment of CKD, and the presence of Diabetes Mellitus (DM) also cause hyperkalemia by decreasing urinary potassium excretion. Metabolic acidosis associated with renal failure leads to potassium shift from intracellular to extracellular and thus hyperkalemia. Most of the daily potassium is excreted by the kidneys while the remaining 5-10% is eliminated by the colon.
- 10 February 2012
- Published by Taylor & Francis in Amyloid
- Vol. 19 (1) , 28-32
The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients
Objective: The aim of this study was to evaluate the relationship of local intrarenal renin angiotensin system (RAS) with proteinuria in patients with renal AA amyloidosis. Methods: Thirty-two patients with renal AA amyloidosis (19 male, mean age: 45 ± 13 years) and sixteen healthy controls (5 male, mean age: 32 ± 5 years) were included in this study. Spot urine samples were obtained to measure urinary angiotensinogen (AGT) using human AGT-ELISA, urinary creatinine and protein levels. Logarithmic transformations of urinary AGT-creatinine ratio log(UAGT/Ucre) and urinary protein-to-creatinine ratio (UPCR) were done to obtain the normal distributions of these parameters. Results: Log(UAGT/UCre) was significantly higher in patients compared with the controls (1.88 ± 0.92 µg/g vs. 1.25 ± 0.70 µg/g; p = 0.023). Importantly a significantly positive correlation was found between log(UAGT/Ucre) and logUPCR in patients (r = 0.595, p = 0.006). Conclusions: Urinary AGT levels are higher in renal AA amyloidosis patients than in controls. Also, there is a significant positive correlation between urinary AGT and proteinuria in renal AA amyloidosis.
- 10 February 2012
- Published by Taylor & Francis in Amyloid
- Vol. 19 (1) , 28-32
The relation between urinary angiotensinogen and proteinuria in renal AA amyloidosis patients
Objective: The aim of this study was to evaluate the relationship of local intrarenal renin angiotensin system (RAS) with proteinuria in patients with renal AA amyloidosis. Methods: Thirty-two patients with renal AA amyloidosis (19 male, mean age: 45 ± 13 years) and sixteen healthy controls (5 male, mean age: 32 ± 5 years) were included in this study. Spot urine samples were obtained to measure urinary angiotensinogen (AGT) using human AGT-ELISA, urinary creatinine and protein levels. Logarithmic transformations of urinary AGT-creatinine ratio log(UAGT/Ucre) and urinary protein-to-creatinine ratio (UPCR) were done to obtain the normal distributions of these parameters. Results: Log(UAGT/UCre) was significantly higher in patients compared with the controls (1.88 ± 0.92 µg/g vs. 1.25 ± 0.70 µg/g; p = 0.023). Importantly a significantly positive correlation was found between log(UAGT/Ucre) and logUPCR in patients (r = 0.595, p = 0.006). Conclusions: Urinary AGT levels are higher in renal AA amyloidosis patients than in controls. Also, there is a significant positive correlation between urinary AGT and proteinuria in renal AA amyloidosis.
- Open Access
- 12 December 2011
- Published by Taylor & Francis in Renal Failure
- Vol. 34 (2) , 235-236
Postural Epigastric Pain: A Challenging Symptom for Cytomegalovirus (CMV) Gastritis
Postural epigastric pain is an uncommon symptom and is hardly acquired unless specifically asked to the patient. Here we present a cytomegalovirus (CMV) gastritis case in a renal transplant patient with postural epigastric pain. A 36-year-old male was admitted to our clinic on the 50th day of renal transplantation with postural epigastric pain. All investigations were unremarkable except biopsy-proven CMV gastritis and increased CMV viral load. The patient was free of symptom after ganciclovir treatment. Postural epigastric pain has not been described together with a clinical entity. Although not proved yet, it can be regarded as a unique symptom of CMV gastritis. Renal transplant patients presenting with postural epigastric pain which is not relieved with acid suppression should raise suspicion of CMV gastritis and this has to be confirmed by endoscopy and biopsy.
- 12 December 2011
- Published by Taylor & Francis in Renal Failure
- Vol. 34 (2) , 235-236
Open AccessPostural Epigastric Pain: A Challenging Symptom for Cytomegalovirus (CMV) Gastritis
Postural epigastric pain is an uncommon symptom and is hardly acquired unless specifically asked to the patient. Here we present a cytomegalovirus (CMV) gastritis case in a renal transplant patient with postural epigastric pain. A 36-year-old male was admitted to our clinic on the 50th day of renal transplantation with postural epigastric pain. All investigations were unremarkable except biopsy-proven CMV gastritis and increased CMV viral load. The patient was free of symptom after ganciclovir treatment. Postural epigastric pain has not been described together with a clinical entity. Although not proved yet, it can be regarded as a unique symptom of CMV gastritis. Renal transplant patients presenting with postural epigastric pain which is not relieved with acid suppression should raise suspicion of CMV gastritis and this has to be confirmed by endoscopy and biopsy.
- Open Access
- 16 September 2011
- Published by Frontiers Media SA in Transplant International
- Vol. 25 (1) , 13-18
Elevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?
The aim of this study was to evaluate the relationship of local intrarenal renin angiotensin system (RAS) with hypertension and proteinuria in renal transplant recipients. Sixty-nine nondiabetic renal transplant recipients (39 male, mean age: 36.3 ± 11.5 years) were included in this study. All patients were in stable condition with GFR greater than 30 ml/min/1.73 m2; (MDRD). Hypertension was defined to be present if there was a recorded diagnosis of hypertension, systolic blood pressure >130 mmHg and/or diastolic blood pressure >80 mmHg according to ambulatory blood pressure monitoring. None of the hypertensive patients were receiving RAS blockers. Spot urine samples were obtained to measure urinary angiotensinogen (AGT) using human AGT-ELISA, urinary creatinine and protein levels. The demographic properties and laboratory findings were similar between hypertensive and normotensive transplant recipients. Urinary AGT–creatinine ratio (UAGT/UCre) was significantly higher in hypertensive patients compared with the normotensives (8.98 ± 6.89 μg/g vs. 5.48 ± 3.33 μg/g; P = 0.037). Importantly, a significantly positive correlation was found between UAGT/Ucre levels and proteinuria in hypertensive patients (P = 0.01, r = 0.405). Local intrarenal RAS probably plays an important role in the development of hypertension and proteinuria in renal transplant recipients.
- 16 September 2011
- Published by Frontiers Media SA in Transplant International
- Vol. 25 (1) , 13-18
Open AccessElevated urinary angiotensinogen a marker of intrarenal renin angiotensin system in hypertensive renal transplant recipients: does it play a role in development of proteinuria in hypertensive renal transplant patients?
The aim of this study was to evaluate the relationship of local intrarenal renin angiotensin system (RAS) with hypertension and proteinuria in renal transplant recipients. Sixty-nine nondiabetic renal transplant recipients (39 male, mean age: 36.3 ± 11.5 years) were included in this study. All patients were in stable condition with GFR greater than 30 ml/min/1.73 m2; (MDRD). Hypertension was defined to be present if there was a recorded diagnosis of hypertension, systolic blood pressure >130 mmHg and/or diastolic blood pressure >80 mmHg according to ambulatory blood pressure monitoring. None of the hypertensive patients were receiving RAS blockers. Spot urine samples were obtained to measure urinary angiotensinogen (AGT) using human AGT-ELISA, urinary creatinine and protein levels. The demographic properties and laboratory findings were similar between hypertensive and normotensive transplant recipients. Urinary AGT–creatinine ratio (UAGT/UCre) was significantly higher in hypertensive patients compared with the normotensives (8.98 ± 6.89 μg/g vs. 5.48 ± 3.33 μg/g; P = 0.037). Importantly, a significantly positive correlation was found between UAGT/Ucre levels and proteinuria in hypertensive patients (P = 0.01, r = 0.405). Local intrarenal RAS probably plays an important role in the development of hypertension and proteinuria in renal transplant recipients.
- 20 July 2011
- Published by Taylor & Francis in Renal Failure
- Vol. 33 (8) , 781-784
Comparison of the Clinical and Laboratory Presentations of Primary and Secondary Glomerular Diseases
To investigate the clinicopathologic correlation of the glomerular diseases and to compare the presentations of primary and secondary glomerular diseases. Two hundred and sixty adult patients (men = 56.2%, mean age = 39.9 ± 16.0 years) who had undergone renal biopsy and been diagnosed with glomerular disease were retrospectively investigated. The information about the demographic and clinical characteristics of the patients, the indications for biopsy, the laboratory parameters, and the pathological results of the biopsies were obtained from the medical records. Primary and secondary glomerulonephritis (GN) groups were compared in terms of their demographic characteristics, indications for biopsy, and laboratory parameters. Percent of patients with primary and secondary GN were 63.5% and 36.5%, respectively. The most common indication for biopsy was nephrotic syndrome (53.8%) in all patients. It was found that presentation with impaired renal function was more prevalent in the secondary GN group when compared with the primary GN group (54.7% vs. 35.8%, p < 0.05). Among the inflammation parameters, the levels of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were found to be significantly higher in the secondary GN group when compared with the primary GN group (ESR = 85.2 ± 30.4 mm/h vs. 56.3 ± 30.7 mm/h, p < 0.001; CRP = 42.1 ± 39.6 mg/L vs. 21.7 ± 40.2 mg/L, p < 0.001). The clinicopathologic correlation of GN was found similar with the larger studies in the literature. This study also indicated that the rate of patients with secondary GN was not low, and the inflammation parameters were higher in the secondary GN groups.
- 20 July 2011
- Published by Taylor & Francis in Renal Failure
- Vol. 33 (8) , 781-784
Comparison of the Clinical and Laboratory Presentations of Primary and Secondary Glomerular Diseases
To investigate the clinicopathologic correlation of the glomerular diseases and to compare the presentations of primary and secondary glomerular diseases. Two hundred and sixty adult patients (men = 56.2%, mean age = 39.9 ± 16.0 years) who had undergone renal biopsy and been diagnosed with glomerular disease were retrospectively investigated. The information about the demographic and clinical characteristics of the patients, the indications for biopsy, the laboratory parameters, and the pathological results of the biopsies were obtained from the medical records. Primary and secondary glomerulonephritis (GN) groups were compared in terms of their demographic characteristics, indications for biopsy, and laboratory parameters. Percent of patients with primary and secondary GN were 63.5% and 36.5%, respectively. The most common indication for biopsy was nephrotic syndrome (53.8%) in all patients. It was found that presentation with impaired renal function was more prevalent in the secondary GN group when compared with the primary GN group (54.7% vs. 35.8%, p < 0.05). Among the inflammation parameters, the levels of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) were found to be significantly higher in the secondary GN group when compared with the primary GN group (ESR = 85.2 ± 30.4 mm/h vs. 56.3 ± 30.7 mm/h, p < 0.001; CRP = 42.1 ± 39.6 mg/L vs. 21.7 ± 40.2 mg/L, p < 0.001). The clinicopathologic correlation of GN was found similar with the larger studies in the literature. This study also indicated that the rate of patients with secondary GN was not low, and the inflammation parameters were higher in the secondary GN groups.